United Guardian (UG) Non Operating Investment Income (2017 - 2026)
United Guardian's (UG) quarterly Non Operating Investment Income came in at $48365.0 in Q2 2026, up 96.8% year-over-year from $24576.0 in Q2 2025, and up 172.6% quarter-over-quarter from $17742.0 in Q1 2026.
Powered by 
Analysis
United Guardian (UG) Non Operating Investment Income (2017 - 2026) Analysis & Trends
United Guardian has disclosed Non Operating Investment Income across 10 years of filings, most recently posting $48365.0 for Q2 2026.
- In Q2 2026, Non Operating Investment Income rose 96.8% year-over-year to $48365.0; the TTM figure through Jun 2026 stood at $63540.0 (up 99.06% YoY), while the FY2025 annual figure was $34359.0, up 27.31% from the prior year.
- Non Operating Investment Income came in at $48365.0 for Q2 2026 at United Guardian, up from $17742.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $108219.0 in Q4 2022 to a low of -$460278.0 in Q2 2022.
- Average Non Operating Investment Income over 5 years is -$46538.6, with a median of $13811.0 recorded in 2023.
- Year-over-year, Non Operating Investment Income slumped 1096.93% in 2022 and surged 428.92% in 2024.
- Over 5 years, Non Operating Investment Income stood at $108219.0 in 2022, then sank by 85.89% to $15272.0 in 2023, then sank by 441.99% to -$52229.0 in 2024, then gained by 25.7% to -$38805.0 in 2025, then jumped by 224.64% to $48365.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Investment Income figures were $48365.0 in Q2 2026, $17742.0 in Q1 2026, and -$38805.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.22 Bn | 626.46 Bn | 17.26 Bn | - |
| 2 | AbbVie | 440.28 Bn | 433.71 Bn | 12.70 Bn | - |
| 3 | Merck | 364.30 Bn | 357.16 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 268.44 Bn | 260.75 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.60 Bn | 146.90 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.31 Bn | 44.31 Bn | - | - |
| 8 | Incyte | 24.98 Bn | 20.45 Bn | 1.57 Bn | 9.81 Mn |
| 9 | United Therapeutics | 21.16 Bn | 18.49 Bn | 683.80 Mn | - |
| 10 | United Guardian | 32.71 Mn | 23.12 Mn | 1.55 Mn | 48,365.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48,365.00 |
| Mar 31, 2026 | 17,742.00 |
| Dec 31, 2025 | -38,805.00 |
| Sep 30, 2025 | 36,238.00 |
| Jun 30, 2025 | 24,576.00 |
| Mar 31, 2025 | 12,350.00 |
| Dec 31, 2024 | -52,229.00 |
| Sep 30, 2024 | 47,223.00 |
| Jun 30, 2024 | -9,501.00 |
| Mar 31, 2024 | 41,496.00 |
| Dec 31, 2023 | 15,272.00 |
| Sep 30, 2023 | -14,357.00 |
| Jun 30, 2023 | 7,479.00 |
| Mar 31, 2023 | 72,701.00 |
| Dec 31, 2022 | 108,219.00 |
| Sep 30, 2022 | -300,526.00 |
| Jun 30, 2022 | -460,278.00 |
| Mar 31, 2022 | -393,660.00 |
| Dec 31, 2021 | -63,437.00 |
| Sep 30, 2021 | -25,108.00 |